Please critique this for accuracy:
Shares of Common Stock due to Purchaser's prior to forward split
404,000 shares OS
Post split 54668.876 * 40 = 2590755.04 shares
This should bring the issued and outstanding equal to 2590755.04 shares.
From the CURRENT REPORT
(a) The authorized capital stock of the Company consists solely of
75,000,000 shares of Company Common Stock, par value $0.00001 per share. There
are 2,404,000 shares of Company Common Stock outstanding, of which 2,000,000
shares are being canceled concurrently with the Closing. No shares of Company
Common Stock are held as treasury shares.
...each share of Purchaser Common Stock issued and outstanding
immediately prior to the Effective Time shall be converted into the right to
receive 0.135319 shares of Company Common Stock pre-Forward Split, or 5.4127574
shares of Company Common Stock post-Forward Split,...
Immediately prior to the closing of the merger the name of the Company will be changed to Welltek Incorporated, the Company's authorized common stock will be increased to 200 million shares, and a 40 for 1 forward split of the Company's issued and outstanding common stock will be effectuated. Concurrently with the closing of the merger each share of MedX common stock issued and outstanding will be converted into 5.4127574 shares of Company common stock. The closing of the merger is subject to standard conditions to closing, as set forth in the Agreement.